Previous Article | Next Article 
Journal of Virology, February 2001, p. 1211-1219, Vol. 75, No. 3
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.3.1211-1219.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Proteinase-Polymerase Precursor as the Active Form
of Feline Calicivirus RNA-Dependent RNA Polymerase
Lai
Wei,1
Jason
S.
Huhn,1
Aaron
Mory,1
Harsh B.
Pathak,1
Stanislav V.
Sosnovtsev,2
Kim Y.
Green,2 and
Craig E.
Cameron1,*
Department of Biochemistry and Molecular
Biology, Pennsylvania State University, University Park,
Pennsylvania,1 and Laboratory of
Infectious Diseases, National Institute of Allergy and Infectious
Diseases, National Institutes of Health, Bethesda,
Maryland2
Received 28 July 2000/Accepted 26 October 2000
 |
ABSTRACT |
The objective of this study was to identify the active form of the
feline calicivirus (FCV) RNA-dependent RNA polymerase (RdRP). Multiple
active forms of the FCV RdRP were identified. The most active enzyme
was the full-length proteinase-polymerase (Pro-Pol) precursor protein,
corresponding to amino acids 1072 to 1763 of the FCV polyprotein
encoded by open reading frame 1 of the genome. Deletion of 163 amino
acids from the amino terminus of Pro-Pol (the Val-1235 amino terminus)
caused a threefold reduction in polymerase activity. Deletion of an
additional one (the Thr-1236 amino terminus) or two (the Ala-1237 amino
terminus) amino acids produced derivatives that were 7- and 175-fold,
respectively, less active than Pro-Pol. FCV proteinase-dependent
processing of Pro-Pol in the interdomain region preceding Val-1235 was
not observed in the presence of a catalytically active proteinase; however, processing within the polymerase domain was observed. Inactivation of proteinase activity by changing the catalytic cysteine-1193 to glycine permitted the production and purification of
intact Pro-Pol. Biochemical analysis of Pro-Pol showed that this enzyme
has properties expected of a replicative polymerase, suggesting that
Pro-Pol is an active form of the FCV RdRP.
 |
INTRODUCTION |
The family Caliciviridae,
positive-strand RNA viruses, comprises four genera:
Vesivirus, Lagovirus, "Norwalk-like viruses," and "Sapporo-like viruses." The last two genera contain human pathogens associated with acute gastroenteritis (5, 8,
15). As a result of the development of molecular tools to
identify human caliciviruses, it has become clear that these viruses
are responsible for the vast majority of food-borne and waterborne outbreaks of viral gastroenteritis in many communities worldwide (8). The development of strategies to treat human
calicivirus infection is compromised by the absence of tissue or organ
culture systems and animal models to study the multiplication of the viruses.
In order to understand the molecular mechanisms governing genome
replication of viruses in this family and to identify host factors
essential for virus multiplication, we have focused on the study of
feline calicivirus (FCV), a member of the genus Vesivirus. This virus grows well in cell culture, and an infectious molecular clone exists that can be used to study the virus life cycle in cell
culture (21). The FCV RNA genome is 7.7 kb in length. The genome has a protein (VPg) linked to the 5' end and is polyadenylated at the 3' end (13a). The genome includes three open
reading frames (ORFs). ORF1 encodes nonstructural proteins, some of
which are homologous to picornavirus nonstructural proteins
(24). For example, 2C-like NTPase, 3C-like proteinase, and
3D-like polymerase motifs have been identified. ORF2 encodes the capsid
protein. ORF3 encodes a protein of unknown function, but recent studies suggest that this protein is a minor component of the virion (13, 23). ORF2- and ORF3-encoded proteins are produced by translation of a subgenomic RNA. This RNA is also VPg linked and polyadenylated (13a).
Central to the genome replication process is the RNA-dependent RNA
polymerase (RdRP). The only calicivirus RdRP that has been purified and
characterized to date is the rabbit hemorrhagic disease virus (RHDV)
enzyme (26). In this system, the active polymerase is
thought to be a 58-kDa protein derived from processing of the ORF1
polyprotein between the proteinase and polymerase domains by the viral
proteinase (26). Our present study was designed to
identify the site of processing within the FCV ORF1 polyprotein used by
the viral proteinase to produce the active form of the FCV polymerase
and to characterize the biochemical properties of this enzyme. In
contrast to the RHDV system, we find that the active form of the FCV
polymerase is the bifunctional proteinase-polymerase (Pro-Pol) protein.
Processing between these domains is not required for RdRP activity.
Biochemical data support the conclusion that Pro-Pol is the active form
of the FCV RdRP. We discuss the possibility that other calicivirus
polymerases may exist as a bifunctional polypeptide.
 |
MATERIALS AND METHODS |
Materials.
[
-32P]UTP (>6,000 Ci/mmol) and
[
-32P]GTP (>3,000 Ci/mmol) were from NEN Life Science
Products; [
-32P]ATP (>7,000 Ci/mmol) was from ICN.
RNA oligonucleotides were from Dharmacon Research; heparin 6000 and
poly(rC) were from Sigma; nucleoside 5'-triphosphates, poly(rA), and
Q-Sepharose were from Amersham Pharmacia Biotech; 2.5-cm-diameter DE81
filter paper disks and phosphocellulose (P11) resin were from Whatman;
polyethyleneimine (PEI)-cellulose thin-layer chromatography (TLC)
plates were from EM Science; Ecoscint scintillation fluid was from
National Diagnostics; T4 polynucleotide kinase and Deep Vent DNA
polymerase were from New England Biolabs; a single-stranded
10-nucleotide (nt) ladder was from Life Technologies; and
Ni-nitrilotriacetic acid (NTA) agarose resin was from Qiagen. All other
reagents were of the highest grade available from Fisher or Sigma.
Construction of expression vectors.
Expression vectors were
prepared by using standard recombinant DNA methods as described
previously (9). Briefly, PCR was used to amplify
polymerase-coding sequence. Forward primers were designed such that
each primer fused coding sequence for the carboxy-terminal three amino
acids of ubiquitin to coding sequence for polymerase derivatives
containing different amino termini: Val-1235, Thr-1236, or Ala-1237
(Table 1, oligonucleotides 1 to 3). These
sequences were located downstream of a SacII site that could
be used for cloning. The reverse primer (Table 1, oligonucleotide 4)
encoded the carboxy-terminal residues of the polymerase domain followed by (i) a Gly-Ser-Ser-Gly linker, (ii) a hexahistidine tag, (iii) stop
codons, and (iv) a SacI site for cloning. The infectious FCV
cDNA clone (pQ14) was used as a template (21).
Gel-purified PCR products were digested with SacII and
SacI and cloned into pET26-Ub (9) to yield
pET26-Ub-FCV-PolVal-1235-his,
pET26-Ub-FCV-PolThr-1236-his, and
pET26-Ub-FCV-Pol-Ala-1237-his. Vectors directing the
expression of full-length Pro-Pol derivatives were also constructed.
These vectors were prepared as described above. The forward primer
(Table 1, oligonucleotide 5) has the standard design for fusion to
ubiquitin, and the coding sequence begins with Ser-1072 of FCV ORF1,
the amino terminus of the proteinase domain (24). In
addition, an oligonucleotide encoding an authentic carboxyl terminus
was also designed (Table 1, oligonucleotide 6). The following
constructs were prepared: pET26-Ub-FCV-Pro-Pol-his,
pET26-Ub-FCV-ProM-Pol-his, and
pET26-Ub-FCV-ProM-Pol. The designation
"ProM" refers to proteinase-coding sequence in which
the codon encoding catalytic Cys-1193 was changed to one encoding a
glycine, thereby producing an inactive proteinase. This particular
mutation and the corresponding template used for PCR has been described
previously (24).
Expression and purification of histidine-tagged polymerase
derivatives.
To express each His-tagged polymerase derivative, the
appropriate plasmid was transformed into Escherichia coli
strain BL21(DE3)(pCG1) (9) and grown at 37°C to an
A600 of 0.8 to 2 in NZCYM medium that contained
25 µg of kanamycin/ml (K25) and 20 µg of chloramphenicol/ml (C20).
The cultures were cooled to 25°C, and expression was induced by the
addition of isopropyl-1-thio-
-D-galactopyranoside (IPTG) to a final concentration of 500 µM. Cells were harvested by
centrifugation after 4 h. The harvested cells were suspended in
lysis buffer (100 mM potassium phosphate) [pH 8.0] 20% glycerol, 0.5 mM EDTA, 1 mM 2-mercaptoethanol, 5.6 µg of pepstatin A/ml, 4.0 µg
of leupeptin/ml) at 4 ml/g of cells. The suspended cells were lysed by
passing them through a French press. Phenylmethylsulfonyl fluoride was added to the cell extract to a final concentration of 2 mM, and nucleic
acid was precipitated by the addition of PEI to a final concentration
of 0.25% (vol/vol). The extract was stirred slowly at 4°C for 20 min
and then centrifuged at 100,000 × g for 35 min. After
the PEI supernatant was decanted, solid ammonium sulfate was added
slowly to 60% saturation and stirred for 20 min at 4°C. The ammonium
sulfate suspension was centrifuged at 100,000 × g for
35 min. The supernatant was decanted, and the pellet was suspended in
buffer A (50 mM Tris [pH 8.0], 20% glycerol, 1 mM 2-mercaptoethanol, 0.1% NP-40, and 60 µM ZnCl2) to a final salt
concentration of 35 mM based upon the conductivity of the sample.
The suspended sample was loaded onto a 1-mL Ni-NTA column at a flow
rate of 0.10 ml/min. The column was washed to baseline
with buffer A
containing 50 mM NaCl. Protein was eluted with 3
column volumes each of
5, 50, and 500 mM imidazole. The 50 and
500 mM fractions were pooled
and diluted in buffer A to a final
salt concentration of 35
mM.
The Ni-NTA pool was loaded onto a 1-ml phosphocellulose column at a
flow rate of 0.12 ml/min. The passthrough was collected
and loaded onto
a 0.5-ml Q-Sepharose column at a flow rate of
0.12 ml/min. The column
was washed to baseline with 50 mM NaCl
in buffer B (50 mM HEPES [pH
7.5], 20% glycerol, 0.1% NP-40, 60
µM ZnCl
2, and 1 mM
dithiothreitol). The His-tagged polymerase
derivatives were eluted from
the column by using buffer B containing
500 mM NaCl. The purity of the
eluted fractions was evaluated
by sodium dodecyl sulfate-polyacrylamide
gel electrophoresis (SDS-PAGE).
The concentration of the final pool was
determined by absorbance
at 280 nm in phosphate-buffered (25 mM; pH
7.0) guanidine (6 M)
using a calculated extinction coefficient, 61,020 M
1cm
1, for all polymerase derivatives
(
7).
Pro
M-Pol-His was expressed and purified as described above
with the following modifications. Ammonium sulfate was added slowly
to
40% saturation. The protein was eluted from the Q-Sepharose
column by
using buffer B containing 2 M NaCl. The calculated extinction
coefficient used for all Pro-Pol enzymes was 78,800 M
1cm
1 (
7).
Expression and purification of ProM-Pol.
Expression and purification of ProM-Pol was performed as
described above for the ProM-Pol-His enzyme through the
ammonium sulfate precipitation step. The ammonium sulfate-precipitated
protein was suspended in buffer A and dialyzed against 10 mM NaCl
overnight. The dialyzed sample was adjusted to 50 mM NaCl and loaded
onto a 25-ml phosphocellulose column at a flow rate of 1 ml/min. The
column was washed to baseline with buffer A containing 50 mM NaCl.
Protein was eluted with a linear gradient (6 column volumes) from 50 to
400 mM NaCl in buffer A, and 2.5-ml fractions were collected. The
purity of the eluted fractions was assessed by SDS-PAGE.
The pool from the phosphocellulose column was adjusted to 50 mM NaCl
and loaded onto a Q-Sepharose column. The subsequent
steps were
identical to those for the phosphocellulose
column.
RdRP activity assays.
RdRP assays were performed in a
reaction mixture of 50 mM HEPES buffer (pH 7.5), 10 mM
2-mercaptoethanol, 5 mM MgCl2, 60 µM ZnCl2,
0.2 µCi of
-32P-nucleoside triphosphate (NTP)/µl,
and 500 µM NTP. The concentrations of primers and templates used,
along with any deviations from the above mentioned reaction conditions,
are listed in the appropriate figure legends. The reactions were
quenched by the addition of EDTA to a final concentration of 250 mM,
unless otherwise specified, and spotted onto DE81 filter paper disks.
The DE81 disks were dried completely and then washed in 5% dibasic
sodium phosphate for 2 min followed by two 5-min washes. The disks were
then rinsed in absolute ethanol. Bound radioactivity was quantitated by
liquid scintillation counting in 5 ml of Ecoscint scintillation fluid.
Purity of
-32P-NTPs.
Dilutions (0.1 µCi/µl) of
-32P-NTPs were made in distilled
deionized water, and 1 µl was spotted in triplicate onto
PE1-cellulose TLC plates. The TLC plates were developed in 0.3 M
potassium phosphate buffer, pH 7.0. The plates were dried and exposed
to a PhosphorImager screen and viewed and quantitated by using
ImageQuant software from Molecular Dynamics. The purity served as a
correction factor for the specific activity of
-32P-NTPs
used in reactions in order to accurately calculate concentrations of products.
PAGE.
The quenched reaction mixtures were mixed with equal
volumes of loading buffer (80% formamide, 100 mM EDTA, 50 mM
Tris-borate, 0.15% xylene cyanol, and 0.15% bromophenol blue).
Samples were heated at 65°C for 3 min before being loaded on a 1×
Tris-borate-EDTA denaturing 10% polyacrylamide gel. A single-stranded
10-nt ladder was also loaded onto the gel. The DNA ladder was labeled
by using [
-32P]ATP and T4 polynucleotide kinase as
specified by Life Technologies, Inc. Electrophoresis was carried out in
1× Tris-borate-EDTA at 90 W. Resolved products were visualized by
using a PhosphorImager.
Construction of transcription plasmid.
Plasmid pGLT7 was
constructed by subcloning the 732-bp NotI fragment of
plasmid pGreenLantern-1 (Gibco BRL) into NotI-digested pSPORT1 vector (Gibco BRL). The resulting plasmid contained the green
fluorescent protein gene under control of the T7 RNA polymerase promoter.
RNA synthesis.
Plasmid pGLT7 was utilized to prepare
heteropolymeric RNA template. The 830-nt-long RNA transcript (GLT7 RNA)
was produced from MluI-linearized plasmid by using Ribomax,
the large-scale RNA production system from Promega. RNA was analyzed by
electrophoresis on 1% agarose gels containing formaldehyde, as
described by Sambrook et al. (19).
RNase T1 digestion.
The product synthesized by FCV
ProM-Pol by using GLT7 RNA as a template was treated with 5 U of RNase T1 (Gibco BRL) for 1 h at 37°C.
Probe preparation.
5' 32P-end-labeled RNA was
used as a probe for Northern blot analysis. To prepare the RNA probe,
25 pmol of GLT7 RNA was dephosphorylated by using 0.25 U of calf
intestinal alkaline phosphatase (Gibco BRL) for 10 min at 37°C. The
reaction was stopped by heating the mixture to 70°C for 10 min, and
RNA was extracted with phenol and then precipitated with ethanol. For
radiolabeling of the RNA 5' end, the RNA pellet was dissolved in 50 µl of buffer containing 70 mM Tris-HCl (pH 7.6), 10 mM
MgCl2, 100 mM KCl, 1 mM
-mercaptoethanol, and 100 µCi
of [
-32P]ATP (5,000 Ci/mmol; Amersham) and incubated
for 15 min at 37°C with 10 U of T4 polynucleotide kinase (Gibco BRL).
The reaction was stopped by heat inactivation (10 min at 70°C), and
the reaction mixture was extracted twice with phenol prior to ethanol
precipitation of RNA.
Northern blot analysis.
Northern blot analysis was performed
under conditions similar to those described previously
(19). Briefly, RNA was separated on a formaldehyde
denaturing 1% agarose gel, transferred to nylon membrane (Schleicher & Schuell), and fixed by UV cross-linking (Stratagene). The blot was
hybridized with 32P-labeled RNA probe, and the
hybridization conditions were 6× SSC buffer (1× SSC is 0.15 M NaCl
plus 0.015 M sodium citrate), 5× Denhardt's solution, 0.1% SDS, and
100 µg of sheared DNA per ml at 65°C overnight. The blot was washed
in 2× SSC-0.1% SDS and exposed to film.
 |
RESULTS |
Construction, expression, purification, and characterization of FCV
polymerase derivatives with different amino termini.
The
calicivirus RdRP belongs to the supergroup I family of RdRPs, and this
supergroup also includes picornavirus RdRPs, such as poliovirus (PV)
3Dpol. In the case of PV polymerase, an authentic amino
terminus is essential for maximal catalytic activity of the enzyme
(9), and precursor forms of the polymerase, such as the
Pro-Pol precursor (3CDpro), lack polymerase activity
(12). Therefore, it seemed reasonable that processing of
the FCV Pro-Pol precursor would be required to release the active form
of the viral polymerase. However, inspection of the amino acid sequence
between defined regions of the FCV proteinase and polymerase domains
failed to reveal any obvious cleavage site
that is, an EG, EA, or ET
dipeptide that conforms to known calicivirus proteinase cleavage sites
(Fig. 1) (6). Furthermore,
previous proteolytic mapping studies of the FCV ORF1-encoded polyprotein failed to identify an efficient processing site in this
region (24).

View larger version (26K):
[in this window]
[in a new window]
|
FIG. 1.
Comparison of the Pro-Pol interdomain linker of FCV to
those from RHDV, SV, Norwalk virus (NV), and Manchester virus (MV). The
sequence alignment was performed with ClustalW; conserved residues are
denoted by asterisks. Established proteinase and polymerase domains,
based upon conserved sequence motifs, are labeled. Processing sites
reported for RHDV (25) and SV (18), as well
as residues evaluated as the amino terminus of the FCV polymerase
domain, are shown in boldface type. The position of each sequence in
the ORF1-encoded polyprotein is indicated. The GenBank accession
numbers are as follows: FCV, L40021; RHDV, M67473; SV, L07418; NV,
M87661; and MV, X86560.
|
|
In order to identify the amino terminus of FCV polymerase, we compared
the FCV Pro-Pol interdomain linker to those from RHDV
and Southampton
virus (SV). This analysis helped to further delimit
the region in which
the cleavage site might be located (Fig.
1).
We set out to construct a
panel of polymerase derivatives beginning
with Val-1235, a residue
conserved among all calicivirus polymerases
and located prior to the
established amino termini of RHDV and
SV polymerases (Fig.
1), and
continuing inwards until the most
active polymerase was produced. The
initial set of constructs
produced polymerase derivatives with the
following amino termini:
Val-1235, Thr-1236, and Ala-1237. The
derivatives were produced
in
E. coli by using a pET
expression system to produce a ubiquitin-polymerase
fusion protein
containing a hexahistidine tag on the carboxy-terminal
end of the
polymerase domain. Only polymerase with the desired
amino terminus
accumulated intracellularly because the ubiquitin
monomer was removed
from the fusion protein by a ubiquitin protease
that was expressed from
a second plasmid (
9). Each polymerase
derivative was
purified to greater-than-90% purity (Fig.
2A) from
the soluble fraction of
E. coli by using a combination of metal
chelate affinity and
ion-exchange chromatographies (see Materials
and Methods). The
authenticity of the amino terminus of each derivative
was verified by
amino-terminal sequencing (data not shown).

View larger version (47K):
[in this window]
[in a new window]
|
FIG. 2.
SDS-PAGE analysis. (A) Purified His-tagged polymerase
derivatives. Lanes: 1, molecular mass markers (in kilodaltons); 2, ProM-Pol-His; 3, PolVal-1235-His; 4, PolThr-1236-His; 5, PolAla-1237-His. (B)
Purification of FCV ProM-Pol. Lanes: 1, molecular mass
markers; 2, uninduced cells; 3, induced cells; 4, lysate; 5, clarified
lysate; 6, 40% ammonium sulfate pellet; 7, phosphocellulose pool; 8, Q-Sepharose pool.
|
|
The polymerase derivatives were assayed in vitro for poly(rU) and
poly(rG) polymerase activity. Each derivative exhibited
detectable
levels of poly(rU) and poly(rG) polymerase activity,
and in each case,
poly(rU) polymerase activity was reduced threefold
relative to poly(rG)
polymerase activity (Table
2). The
Val-1235
derivative was most active (30 to 100 pmol of nucleotide
incorporated/min/µg
of protein). Deletion of the valine (the Thr-1236
derivative)
caused a threefold reduction in polymerase activity
relative to
the Val-1235 enzyme; deletion of the threonine (the
Ala-1237 derivative)
caused a 90-fold reduction in polymerase activity
relative to
the Val-1235 enzyme (Table
2). These data suggested that
the
boundary for the active form of the polymerase was located either
at Val-1235 or at a position amino terminal to this residue.
Identification of the FCV Pro-Pol precursor as an active form of
the RdRP.
Instead of systematically adding residues to the amino
terminus of the Val-1235 derivative, we constructed an expression
vector that produced the authentically processed, wild-type Pro-Pol
precursor (see Materials and Methods). When this protein was expressed
in E. coli, proteolytic processing was observed. While some
of the proteolytic processing was due to bacterial proteinases, some could be attributed to the viral proteinase as well (reference 24 and data not shown). Consistent with previous studies
of FCV polyprotein processing, the sites in the Pro-Pol precursor recognized by the viral proteinase were located in regions of the
polymerase essential for catalytic function (24). In order to preclude processing within the polymerase domain, a mutation was
introduced into the proteinase-coding sequence that changed the
active-site Cys-1193 to glycine. This derivative is referred to here as
ProM-Pol. In addition, we constructed a derivative
containing a hexahistidine tag on the carboxyl terminus of the
polymerase domain (ProM-Pol-His) to permit a direct
comparison to the truncated polymerase derivatives. The
ProM-Pol-His derivative was expressed and purified as
described for the truncated enzymes (Fig. 2A). This derivative was
threefold more active than the Val-1235 enzyme when either poly(rU) or
poly(rG) polymerase activity was evaluated, indicating that the Pro-Pol precursor was an active RdRP.
Purification of ProM-Pol.
It remained possible
that the presence of the hexahistidine tag on the carboxyl terminus of
the polymerase altered the activity of the enzyme. In order to test
this possibility, we developed a purification procedure for the
ProM-Pol enzyme. ProM-Pol was produced in
E. coli by using the pET-ubiquitin-ubiquitin protease system
(9). ProM-Pol accumulated in the soluble
fraction to levels on the order of 5% of the total cellular protein
(Fig. 2B, lanes 2 to 5, and Table 3). The
enzyme was purified to at least 95% purity in three steps: (i)
ammonium sulfate precipitation (Fig. 2B, lane 6, and Table 3); (ii)
phosphocellulose chromatography (Fig. 2B, lane 7, and Table 3); and
(iii) Q-Sepharose chromatography (Fig. 2B, lane 8, and Table 3). The
final yield from 30 g (wet weight) of cells was 75 mg of protein
(Table 3).
Characterization of ProM-Pol by using homopolymeric
primer-template duplexes.
The poly(rU) and poly(rG) polymerase
activity of ProM-Pol was evaluated and shown to be within
experimental error of the values determined for the
ProM-Pol-His derivative (Table 2). DNA
[T(pT)14] and RNA [U(pU)14] oligonucleotides served equally well as primers in this assay (data not
shown). The kinetics of RNA synthesis were biphasic with both
homopolymeric primer-template duplexes analyzed (Fig. 3 and data not shown). Evaluation of the
product formed after 3 min no longer provided useful information on the
true initial rate of the reaction (Fig. 3). The reduction in the
observed rate of the reaction was not due to substrate depletion, as
only 10% of the nucleotide was consumed after a 20-min incubation
(Fig. 3). The most reasonable explanation for the observed reduction in
activity was thermal inactivation of ProM-Pol. This
conclusion was based upon the finding that ProM-Pol has a
half-life of approximately 1 min in reaction buffer at 30°C (Table
4). The linearity of the reactions shown
in Fig. 3 for periods longer than 1 min likely reflects stabilization of the enzyme by nucleotide and/or nucleic acid (3).
Polymerase activity was also sensitive to the presence of salt in the
reaction; 30 mM NaCl caused a 50% reduction in activity (Table 4).

View larger version (15K):
[in this window]
[in a new window]
|
FIG. 3.
Kinetics of GMP incorporation. The reaction mixtures
contained ProM-Pol (0.66 µM), poly(rC) (93.4 µM CMP),
and 4.70 µM oligo(dG)6 (28 µM GMP). The reaction
mixtures were incubated at 30°C for 5 min, followed by initiation
with ProM-Pol. The reactions were quenched at the indicated
times by addition of EDTA. The reaction volume was 50 µl.
|
|
A template-specific primer length dependence was observed (Fig.
4). When poly(rA) was employed as a
template, a 10-nt primer
was optimal (Fig.
4A). However, when poly(rC)
was employed as
a template, a 6-nt primer was optimal (Fig.
4B).
Increasing the
length of the oligo(dT) primers above 10 nt decreased
polymerase
activity (Fig.
4A). With each primer, the fraction of
nucleic
acid template devoid of primer remained constant. Therefore,
the
amount of nucleotide incorporated per bound primer should be
independent
of primer length. The observed decrease in the product
formed
as primer length increased may reflect an increase in the number
of unproductive complexes formed as a result of the enzyme active
site
being located at internal positions of the duplex rather
than at the 3'
end of the primer. Increasing the length of the
oligo(dG) primers was
not inhibitory (Fig.
4B). Perhaps the tertiary
structures adopted by
deoxyguanylate repeats prevented complete
annealing of these primers to
the template (
20). The 6-nt oligo(dT)
primer was not as
good as the 10-nt primer (Fig.
4A), suggesting
that the thermal
stability of the primer-template duplex was more
important than length
for maximal activity. With the poly(rC)
template, primer-independent
RNA synthesis was also noted (Fig.
4B).

View larger version (16K):
[in this window]
[in a new window]
|
FIG. 4.
Effect of primer length on
ProM-Pol-catalyzed RNA synthesis. (A) Synthesis of
poly(rU). ProM-Pol (1 µM) was assayed at 30°C for
poly(rU) polymerase activity as a function of oligo(dT) primer length.
The reaction mixtures contained 0.2 µM poly(rA) (93.4 µM AMP) and
oligo(dT)n (where n = 6, 10, 15, or 20). Concentrations of primer sufficient to coat 30% of the
homopolymeric template were used. The reactions were initiated by the
addition of ProM-Pol and quenched after 1 min by the
addition of EDTA. The reaction volume was 30 µl. (B) Synthesis of
poly(rG). Reactions were performed as described above, except poly(rC),
oligo(dG)n, and GTP were used.
|
|
While the activity of Pro
M-Pol reported here was
~300,000-fold greater than the activity of the polymerase derivative
reported
for RHDV (
26), this enzyme was still
significantly less active
(~10-fold) than PV 3D
pol under
the same reaction conditions (
1). One possible explanation
for this difference was that the divalent cation specificity of
Pro
M-Pol was different than that of the PV polymerase. We
performed
experiments with Pro
M-Pol in which poly(rU) and
poly(rG) polymerase activity was measured
by using a
dT
15-rA
30 or dG
15-rC
30
primer-template duplex, respectively;
Mn
2+ was employed as
the divalent cation cofactor. These experiments
required the use of a
30-nt oligo(rA) template rather than the
longer poly(rA) template owing
to the insolubility of high concentrations
of poly(rA) in the presence
of Mn
2+ (
2). While poly(rC) does not suffer
from the same complication,
a 30-nt oligo(rC) template was employed in
order to facilitate
comparison. Interestingly, the response of
Pro
M-Pol to Mn
2+ was substrate dependent.
Poly(rU) polymerase activity was inhibited
(Table
5) while poly(rG) polymerase activity was
stimulated (Table
5) in the presence of Mn
2+. This
substrate-dependent difference likely reflects changes
in nucleic acid
structure induced by Mn
2+ that in turn modulate the ability
of Pro
M-Pol to bind primer-template duplexes and/or extend
primers. The
10-fold increase in poly(rG) polymerase activity observed
in the
presence of Mn
2+ was still 10-fold less than that
observed for the PV polymerase
(
2). Therefore, a change in
divalent cation specificity was
not sufficient to explain the reduced
activity of Pro
M-Pol compared to that of 3D
pol.
The activity of PV polymerase observed by using homopolymeric
primer-template duplexes derives from a few elongating enzymes
incorporating nucleotides not only by extending primers to the
ends of
templates but also by using slippage and template-switching
mechanisms
(
1). Therefore, another possible explanation for
the
difference in activity between Pro
M-Pol and
3D
pol was that Pro
M-Pol was less efficient at
slippage and/or template switching.
In order to test this possibility,
the following experiment was
performed. Pro
M-Pol (5 µM)
was incubated with dG
15-rC
30 (10 µM) and a
limiting
concentration of radiolabeled GTP (0.25 µM; the total
concentration
of GTP was 1 µM) to incorporate label into bound
primers. After
a 1-min labeling period, GTP (500 µM) and heparin (10 µM) were
added to chase the initiated primers into final products
without
reinitiation. Heparin prevents reinitiation (reference
1 and
data not shown). During the initial labeling period,
products
ranging from 16 to 40 nt in length were observed by using
Pro
M-Pol (Fig.
5). This
product distribution was consistent with the
15-nt primer being
annealed randomly over the entire length of
the 30-nt template. A
similar pattern was observed by using PV
3D
pol
(
1). During the chase, products ranging in length from 40
to 100 nt were produced (Fig.
5). Both the efficiency and length
distribution of long-product formation were reduced significantly
relative to those observed for PV 3D
pol (
1).
This result suggested that the primary difference between
the FCV and
PV polymerases was that the FCV enzyme was less efficient
at template
switching.

View larger version (103K):
[in this window]
[in a new window]
|
FIG. 5.
Template switching catalyzed by FCV polymerase
derivatives. The initial reaction mixtures contained
dG15-rC30 (10 µM), [ -32P]GTP
(0.25 µM), and GTP (0.75 µM) and were initiated by the addition of
enzyme (5 µM) followed by incubation at 30°C for 1 min. Heparin (10 µM) and GTP (500 µM) were added, and at the specified times ( t),
the reactions were quenched by the addition of EDTA to a final
concentration of 50 mM. The final concentrations of
dG15-rC30, [ -32P]GTP, and
enzyme were 1, 0.025, and 0.5 µM, respectively. The labeled products
were resolved by electrophoresis on a denaturing 10% polyacrylamide
gel.
|
|
As expected, the outcome of the experiment was unchanged by using the
Pro
M-Pol-His derivative (Fig.
5). However, the ability of
the truncated
polymerase derivatives to undergo template switching was
compromised
still further relative to the Pro
M-Pol and
Pro
M-Pol-His enzymes. The processivity of each polymerase
derivative
was also decreased based upon the accumulation of products
in
the 40-nt range (Fig.
5). The processivity of the derivatives
followed the order of activity reported in Table
2. The dramatic
reduction in activity of the Ala-1237 derivative must be related
to a
decrease in the efficiency of assembly of this enzyme on
the
primer-template because the overall labeling of primers was
reduced
significantly relative to the other polymerase derivatives
without a
substantial change in the product
distribution.
In general, the biochemical properties of FCV Pro
M-Pol are
very similar to those reported for PV 3D
pol (
1,
2).
Characterization of ProM-Pol by using a heteropolymeric
template.
While the analysis of ProM-Pol on
homopolymeric primer-template duplexes was quite useful for comparison
of the activity of this enzyme to those of others, the biologically
relevant nucleic acid substrate is heteropolymeric. We evaluated the
ability of ProM-Pol to utilize a heteropolymeric RNA
template. This RNA encodes the green fluorescent protein and was
produced by in vitro transcription (see Materials and Methods). The RNA
is 830 nt in length (Fig. 6, left).
Incubation of ProM-Pol with this template and nucleotides
followed by denaturing agarose gel electrophoresis showed that the
enzyme was capable of copying the entire template (Fig. 6, left).
However, the product RNA was twice the size of the input RNA as
previously observed with RHDV polymerase (26), suggesting
that the product RNA was covalently linked to the template. Template
RNA can form a hairpin loop at the 3' end due to the restriction enzyme
used to linearize the template for in vitro transcription. Utilization
of this 3' end as a primer would produce a covalently linked, dimer
length RNA product that is sensitive to the single-strand-specific
RNase T1. After RNase T1 digestion of the product, electrophoresis
under denaturing conditions, and Northern blot analysis with labeled template, a single-stranded RNA product was observed (Fig. 6, right),
thus confirming that template and product RNAs were connected by a
single-stranded RNA loop.

View larger version (83K):
[in this window]
[in a new window]
|
FIG. 6.
Analysis of RNA product synthesized by FCV
ProM-Pol on heteropolymeric RNA template. GLT7 RNA (3 pmol)
was employed in a transcription reaction with FCV ProM-Pol
(30 pmol). The RNA template and the transcription reaction product
corresponding to an equivalent amount of the template were
electrophoresed on a formaldehyde 1% agarose gel and visualized by
ethidium bromide (Et. Br.) staining (left). The RNA ladder shown in the
gel consists of RNA molecules with sizes of 7.46, 4.40, 2.37, 1.35, and
0.24 kb (from top to bottom of the gel). The same amount of
transcription product was treated with 5 U of RNase T1 for 1 h at
37°C and analyzed by Northern blotting together with the untreated
product and template (right). The RNA bands were visualized by
hybridization with the 5'-end-labeled GLT7 RNA (see Materials and
Methods).
|
|
 |
DISCUSSION |
This study was designed to identify the active form of the FCV
RdRP. In contrast to a previous report (26), our data were most consistent with the Pro-Pol precursor being the primary, active
form of the polymerase. Proteolytic processing between the proteinase
and polymerase domains of the Pro-Pol precursor was not required for
activity. In fact, the most active enzyme was a precursor
(ProM-Pol) in which proteinase activity had been
inactivated by site-directed mutagenesis. Biological studies also
support our conclusion that Pro-Pol is the active form of the FCV RdRP;
only the Pro-Pol precursor accumulates to significant levels when FCV
is grown in cell culture (24).
The only other active calicivirus RdRP reported to date is that from
RHDV (26). The enzyme characterized in that system lacked
the proteinase domain and did not contain an authentic amino terminus
owing to the expression system used. The specific poly(rU) polymerase
activity of this enzyme was ~0.3 fmol/min/µg, a value that is
105- to 106-fold lower than that reported here
for FCV ProM-Pol. Several possible reasons exist for the
difference between the activity of the RHDV and FCV polymerases; none
of these explanations are mutually exclusive. First, the additional
three residues (Gly-Ser-Met) linked to the amino terminus of the RHDV
polymerase derivative might be deleterious to enzyme activity. Indeed,
extension of the amino terminus of PV 3Dpol by addition of
a single glycine caused a 50-fold reduction in polymerase activity
(9). Second, the enzyme may have been partially inactivated by the 3-h incubation at room temperature that was required
for thrombin to cleave the glutathione S-transferase domain
from the glutathione S-transferase-RHDV polymerase fusion protein and release RHDV polymerase (26). As indicated in
Table 4, the activity of the FCV ProM-Pol enzyme was
reduced ~10-fold by a mere 5-min incubation at 30°C in the absence
of nucleotide and nucleic acid. Finally, it is possible that the active
form of the RHDV polymerase is the Pro-Pol precursor. This possibility
was not explored in the previous study (26). The reduced
activity of the RHDV enzyme would then be explained by the loss of
residues essential for function. The amino terminus of RHDV polymerase
has been mapped to threonine-1252 of the RHDV ORF1-encoded polyprotein
(Fig. 1) (25). Based upon our alignment of the FCV, RHDV,
and SV Pro-Pol proteins, this threonine is located carboxy terminal to
FCV Ala-1237 (Fig. 1). Therefore, the RHDV enzyme might be expected to
have less activity than the FCV Ala-1237 derivative. However, our data
are not sufficient to predict the magnitude of the reduction. The FCV
Ala-1237 derivative is 250-fold less active than the
ProM-Pol enzyme (Table 2).
We hypothesize that the primary, active form of RHDV polymerase is the
Pro-Pol protein. RHDV Pro-Pol accumulates in virus-infected hepatocytes, based upon experiments reported by Konig and colleagues (16). In addition, expression of a truncated precursor
containing residues amino terminal and carboxy terminal to the
proteinase domain in E. coli showed that only cleavage to
release the amino terminus of the proteinase is efficient; cleavage
between the proteinase and polymerase domains does not occur readily
(25). Recently, a more quantitative analysis of the
proposed RHDV Pro-Pol cleavage site was performed which predicts that
less than 8% of Pro-Pol molecules should be cleaved to release the
polymerase domain (14). Initial studies of SV polyprotein
processing showed that precursors larger than Pro-Pol accumulate when
translation in vitro occurs in the presence of a full-length genome
(17). Expression of truncated SV precursors in E. coli permits the observation of additional processing to liberate
a polymerase domain (18). In light of the observations
made here, when Pro-Pol processing is evaluated in the future, a
quantitative analysis of the products of proteolysis is warranted.
In the PV system, it has been shown that the Pro-Pol precursor,
3CDpro, accumulates in virus-infected cells
(12). However, 3CDpro lacks polymerase
activity in vitro. The necessity for processing of 3CDpro
to yield 3Dpol, the active form of the PV polymerase, was
clearly the primary reason that investigators studying caliciviruses
searched for processing of the Pro-Pol protein (14, 17, 18, 24,
25). We are therefore forced to ask the question: why is FCV
Pro-Pol an active polymerase but PV 3CDpro an inactive
polymerase? It is likely that the difference in activity observed for
FCV and PV Pro-Pol proteins reflects differences in the conformation of
the proteinase domain relative to the polymerase domain in each
full-length protein. In the FCV Pro-Pol protein, there is a longer
linker between the end of the proteinase domain and the beginning of
the polymerase domain than in PV 3CDpro (Fig. 1 and data
not shown). Therefore, in the case of FCV Pro-Pol, each domain may fold
and function independently of the other. In addition, the absence of an
efficient proteinase cleavage site between the two domains in FCV could
diminish intra- and/or intermolecular interactions between the
proteinase domain and the interdomain linker of Pro-Pol that might
occur with PV 3CDpro. This interaction could perturb the
structure of the 3CDpro polymerase domain, causing the
observed loss of polymerase activity. An unobstructed amino-terminal
subdomain of the polymerase is required for activity because the first
eight amino acids are predicted to form a
-strand that interacts
with two other strands from the finger domain to create a
-sheet
that helps to maintain part of the template-binding site in an open
conformation (4, 10, 11).
The activity of FCV ProM-Pol was decreased 10-fold relative
to that of PV 3Dpol on homopolymeric primer-templates
duplexes owing to an apparent reduction in the efficiency of
ProM-Pol-catalyzed template switching (Fig. 5). Template
switching is thought to be the primary mechanism for recombination
between viral genomes (1). Therefore, if FCV
ProM-Pol is, in fact, the active form of the polymerase,
then the recombination frequency of FCV should be lower than that of
PV. More importantly, because our experiments with FCV
ProM-Pol were performed with the same substrates and under
the same reaction conditions employed for PV 3Dpol
(1), it is possible to conclude for the first time that
polymerase sequence and structure can be as much of a determinant of
recombination efficiency as nucleic acid sequence and structure.
Our data do not rule out the possibility that active forms of the
polymerase shorter than full-length Pro-Pol exist and have some
function. For example, it is possible that some caliciviruses have
evolved to have one form of the polymerase for synthesis of genomic RNA
and another form for synthesis of subgenomic RNA. Alternatively, one
form may be used for initiation of RNA synthesis (e.g., with VPg
priming) and the other for elongation. A final possibility is that
Pro-Pol-Pol hetero-oligomers may have a unique function.
The cleavages within the FCV polymerase domain by the proteinase
(24) should inactivate the catalytic and RNA-binding
activities of the protein based upon a comparison of the FCV polymerase
domain to the PV and hepatitis C virus polymerases (4,
10). This inactivation may not be an artifact of overexpression
of Pro-Pol precursors in systems such as E. coli but may be
relevant biologically. For example, functional polymerase not actively
engaged in RNA synthesis may inhibit elongating enzymes by binding
randomly to template RNA. A mechanism to inactivate these idle enzymes
would preclude this problem. In addition, processing within the
polymerase domain should prevent "spatial" restriction of the
proteinase resulting from interaction of polymerase with RNA and/or
modulate the substrate specificity of the proteinase. In the PV system, 3CDpro cleaves capsid proteins more efficiently than
3Cpro (12). Finally, it is possible that these
proteinase cleavage sites are only exposed in misfolded Pro-Pol
molecules. If this is the case, then the presence of these sites may
provide a quality control mechanism that ensures the removal of
misfolded Pro-Pol, which could interfere with efficient virus multiplication.
In conclusion, this study confirms the functional similarity among
supergroup I RdRPs and illuminates the differences that can exist among
polymerases within a supergroup. The most striking difference among
virus systems that warrants further investigation is the variable
nature of the polymerase polypeptide
that is, mono- versus
bifunctional. Did one form arise before the other? Is one form more
advantageous than the other? The ability to apply reverse genetics to
the study of FCV multiplication should permit us to address these and
related questions directly. Analysis of other calicivirus systems will
be necessary to determine whether the observations reported here for
FCV reflect a general rule for this virus family.
 |
ACKNOWLEDGMENT |
C.E.C. is the recipient of a Howard Temin Award (CA75118) from
the National Cancer Institute, NIH.
 |
FOOTNOTES |
*
Corresponding author. Mailing address: Department of
Biochemistry and Molecular Biology, Pennsylvania State University, 201 Althouse Laboratory, University Park, PA 16802. Phone: (814) 863-8705. Fax: (814) 863-7024. E-mail: cec9{at}psu.edu.
 |
REFERENCES |
| 1.
|
Arnold, J. J., and C. E. Cameron.
1999.
Poliovirus RNA-dependent RNA polymerase (3Dpol) is sufficient for template switching in vitro.
J. Biol. Chem.
274:2706-2716[Abstract/Free Full Text].
|
| 2.
|
Arnold, J. J.,
S. K. B. Ghosh, and C. E. Cameron.
1999.
Poliovirus RNA-dependent RNA polymerase (3Dpol): divalent cation modulation of primer, template, and nucleotide selection.
J. Biol. Chem.
274:37060-37069[Abstract/Free Full Text].
|
| 3.
|
Arnold, J. J., and C. E. Cameron.
2000.
Poliovirus RNA-dependent RNA polymerase (3Dpol): assembly of stable, elongation-competent complexes by using a symmetrical primer-template substrate (sym/sub).
J. Biol. Chem.
275:5329-5336[Abstract/Free Full Text].
|
| 4.
|
Bressanelli, S.,
L. Tomei,
A. Roussel,
I. Incitti,
R. L. Vitale,
M. Mathieu,
R. De Francesco, and F. A. Rey.
1999.
Crystal structure of the RNA-dependent RNA polymerase of hepatitis C virus.
Proc. Natl. Acad. Sci. USA
96:13034-13039[Abstract/Free Full Text].
|
| 5.
|
Chiba, S.,
S. Nakata,
K. Numata-Kinoshita, and S. Honma.
2000.
Sapporo virus: history and recent findings.
J. Infect. Dis.
181:S303-S308.
|
| 6.
|
Clarke, I. N., and P. R. Lambden.
1997.
The molecular biology of caliciviruses.
J. Gen. Virol.
78:291-301[Medline].
|
| 7.
|
Gill, S. C., and P. H. von Hippel.
1989.
Calculation of protein extinction coefficients from amino acid sequence data.
Anal. Biochem.
182:319-326[CrossRef][Medline].
|
| 8.
|
Glass, R. I.,
J. Noel,
T. Ando,
R. Fankhauser,
G. Belliot,
A. Mounts,
U. D. Parashar,
J. S. Bresee, and S. S. Monroe.
2000.
The epidemiology of enteric caliciviruses from humans: a reassessment using new diagnostics.
J. Infect. Dis.
181:S254-S261.
|
| 9.
|
Gohara, D. W.,
C. S. Ha,
S. K. B. Ghosh,
J. J. Arnold,
T. J. Wisniewski, and C. E. Cameron.
1999.
Production of "authentic" poliovirus RNA-dependent RNA polymerase (3Dpol) by ubiquitin-protease-mediated cleavage in Escherichia coli.
Protein Expr. Purif.
17:128-138[CrossRef][Medline].
|
| 10.
|
Gohara, D. W.,
S. Crotty,
J. J. Arnold,
J. D. Yoder,
R. Andino, and C. E. Cameron.
2000.
Poliovirus RNA-dependent RNA polymerase (3Dpol): structural, biochemical, and biological analysis of conserved structural motifs A and B.
J. Biol. Chem.
275:25523-25532[Abstract/Free Full Text].
|
| 11.
|
Hansen, J. L.,
A. M. Long, and S. C. Schultz.
1997.
Structure of the RNA-dependent RNA polymerase of poliovirus.
Structure
5:1109-1122[Abstract/Free Full Text].
|
| 12.
|
Harris, K. S.,
S. R. Reddigari,
M. J. Nicklin,
T. Hammerle, and E. Wimmer.
1992.
Purification and characterization of poliovirus polypeptide 3CD, a proteinase and a precursor for RNA polymerase.
J. Virol.
66:7481-7489[Abstract/Free Full Text].
|
| 13.
|
Herbert, T. P.,
I. Brierley, and T. D. Brown.
1996.
Detection of the ORF3 polypeptide of feline calicivirus and evidence for its expression from a single, functionally bicistronic, subgenomic mRNA.
J. Gen. Virol.
77:123-127[Abstract/Free Full Text].
|
| 13a.
|
Herbert, T. P.,
I. Brierley, and T. D. Brown.
1997.
Identification of a protein linked to the genomic and subgenomic mRNAs of feline calicivirus and its role in translation.
J. Gen. Virol.
78:1033-1040[Abstract].
|
| 14.
|
Joubert, P.,
C. Pautigny,
M. Madelaine, and D. Rasschaert.
2000.
Identification of a new cleavage site of the 3C-like protease of rabbit haemorrhagic disease virus.
J. Gen. Virol.
81:481-488[Abstract/Free Full Text].
|
| 15.
|
Kapikian, A. Z.,
M. K. Estes, and R. M. Chanock.
1996.
Norwalk group of viruses, p. 783-810.
In
B. N. Fields, D. M. Knipe, P. M. Howley, R. M. Chanock, J. L. Melnick, T. P. Monath, B. Roizman, and S. E. Straus (ed.), Fields virology, 3rd ed. Lippincott-Raven Publishers, Philadelphia, Pa.
|
| 16.
|
Konig, M.,
H. J. Thiel, and G. Meyers.
1998.
Detection of viral proteins after infection of cultured hepatocytes with rabbit hemorrhagic disease virus.
J. Virol.
72:4492-4497[Abstract/Free Full Text].
|
| 17.
|
Liu, B.,
I. N. Clarke, and P. R. Lambden.
1996.
Polyprotein processing in southampton virus: identification of 3C-like protease cleavage sites by in vitro mutagenesis.
J. Virol.
70:2605-2610[Abstract].
|
| 18.
|
Liu, B. L.,
G. J. Viljoen,
I. N. Clarke, and P. R. Lambden.
1999.
Identification of further proteolytic cleavage sites in the southampton calicivirus polyprotein by expression of the viral protease in E. coli.
J. Gen. Virol.
80:291-296[Abstract].
|
| 19.
|
Sambrook, J. E.,
E. F. Fritsch, and T. Maniatis.
1989.
Molecular cloning: a laboratory manual, 2nd ed.
Cold Spring Harbor Laboratory, Cold Spring Harbor, N.Y.
|
| 20.
|
Smith, F. W., and J. Feigon.
1992.
Quadruplex structure of oxytricha telomeric DNA oligonucleotides.
Nature
356:164-168[CrossRef][Medline].
|
| 21.
|
Sosnovtsev, S., and K. Y. Green.
1995.
RNA transcripts derived from a cloned full-length copy of the feline calicivirus genome do not require VpG for infectivity.
Virology
210:383-390[CrossRef][Medline].
|
| 22.
|
Sosnovtsev, S. V.,
S. A. Sosnovtseva, and K. Y. Green.
1998.
Cleavage of the feline calicivirus capsid precursor is mediated by a virus-encoded proteinase.
J. Virol.
72:3051-3059[Abstract/Free Full Text].
|
| 23.
|
Sosnovtsev, S. V., and K. Y. Green.
2000.
Identification and genomic mapping of the ORF3 and VPg proteins in feline calicivirus virions.
Virology
277:193-203[CrossRef][Medline].
|
| 24.
|
Sosnovtseva, S. A.,
S. V. Sosnovtsev, and K. Y. Green.
1999.
Mapping of the feline calicivirus proteinase responsible for autocatalytic processing of the nonstructural polyprotein and identification of a stable proteinase-polymerase precursor protein.
J. Virol.
73:6626-6633[Abstract/Free Full Text].
|
| 25.
|
Wirblich, C.,
M. Sibilia,
M. B. Boniotti,
C. Rossi,
H. J. Thiel, and G. Meyers.
1995.
3C-like protease of rabbit hemorrhagic disease virus: identification of cleavage sites in the ORF1 polyprotein and analysis of cleavage specificity.
J. Virol.
69:7159-7168[Abstract].
|
| 26.
|
Vázquez, A. L.,
J. M. M. Alonso,
R. Casais,
J. A. Boga, and F. Parra.
1998.
Expression of enzymatically active rabbit hemorrhagic disease virus RNA-dependent RNA polymerase in Escherichia coli.
J. Virol.
72:2999-3004[Abstract/Free Full Text].
|
Journal of Virology, February 2001, p. 1211-1219, Vol. 75, No. 3
0022-538X/01/$04.00+0 DOI: 10.1128/JVI.75.3.1211-1219.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Oka, T., Yamamoto, M., Yokoyama, M., Ogawa, S., Hansman, G. S., Katayama, K., Miyashita, K., Takagi, H., Tohya, Y., Sato, H., Takeda, N.
(2007). Highly Conserved Configuration of Catalytic Amino Acid Residues among Calicivirus-Encoded Proteases. J. Virol.
81: 6798-6806
[Abstract]
[Full Text]
-
Fullerton, S. W. B., Blaschke, M., Coutard, B., Gebhardt, J., Gorbalenya, A., Canard, B., Tucker, P. A., Rohayem, J.
(2007). Structural and Functional Characterization of Sapovirus RNA-Dependent RNA Polymerase. J. Virol.
81: 1858-1871
[Abstract]
[Full Text]
-
Karakasiliotis, I., Chaudhry, Y., Roberts, L. O., Goodfellow, I. G.
(2006). Feline calicivirus replication: requirement for polypyrimidine tract-binding protein is temperature-dependent.. J. Gen. Virol.
87: 3339-3347
[Abstract]
[Full Text]
-
Sosnovtsev, S. V., Belliot, G., Chang, K.-O., Prikhodko, V. G., Thackray, L. B., Wobus, C. E., Karst, S. M., Virgin, H. W., Green, K. Y.
(2006). Cleavage map and proteolytic processing of the murine norovirus nonstructural polyprotein in infected cells.. J. Virol.
80: 7816-7831
[Abstract]
[Full Text]
-
Kaiser, W. J., Chaudhry, Y., Sosnovtsev, S. V., Goodfellow, I. G.
(2006). Analysis of protein-protein interactions in the feline calicivirus replication complex. J. Gen. Virol.
87: 363-368
[Abstract]
[Full Text]
-
Oka, T., Katayama, K., Ogawa, S., Hansman, G. S., Kageyama, T., Ushijima, H., Miyamura, T., Takeda, N.
(2005). Proteolytic Processing of Sapovirus ORF1 Polyprotein. J. Virol.
79: 7283-7290
[Abstract]
[Full Text]
-
Belliot, G., Sosnovtsev, S. V., Chang, K.-O., Babu, V., Uche, U., Arnold, J. J., Cameron, C. E., Green, K. Y.
(2005). Norovirus Proteinase-Polymerase and Polymerase Are Both Active Forms of RNA-Dependent RNA Polymerase. J. Virol.
79: 2393-2403
[Abstract]
[Full Text]
-
Ng, K. K.-S., Pendas-Franco, N., Rojo, J., Boga, J. A., Machin, A., Alonso, J. M. M., Parra, F.
(2004). Crystal Structure of Norwalk Virus Polymerase Reveals the Carboxyl Terminus in the Active Site Cleft. J. Biol. Chem.
279: 16638-16645
[Abstract]
[Full Text]
-
Fukushi, S., Kojima, S., Takai, R., Hoshino, F. B., Oka, T., Takeda, N., Katayama, K., Kageyama, T.
(2004). Poly(A)- and Primer-Independent RNA Polymerase of Norovirus. J. Virol.
78: 3889-3896
[Abstract]
[Full Text]
-
Belliot, G., Sosnovtsev, S. V., Mitra, T., Hammer, C., Garfield, M., Green, K. Y.
(2003). In Vitro Proteolytic Processing of the MD145 Norovirus ORF1 Nonstructural Polyprotein Yields Stable Precursors and Products Similar to Those Detected in Calicivirus-Infected Cells. J. Virol.
77: 10957-10974
[Abstract]
[Full Text]
-
Oehmig, A., Buttner, M., Weiland, F., Werz, W., Bergemann, K., Pfaff, E.
(2003). Identification of a calicivirus isolate of unknown origin. J. Gen. Virol.
84: 2837-2845
[Abstract]
[Full Text]
-
Seah, E. L., Marshall, J. A., Wright, P. J.
(2003). trans Activity of the Norovirus Camberwell Proteinase and Cleavage of the N-Terminal Protein Encoded by ORF1. J. Virol.
77: 7150-7155
[Abstract]
[Full Text]
-
Ziebuhr, J., Bayer, S., Cowley, J. A., Gorbalenya, A. E.
(2002). The 3C-Like Proteinase of an Invertebrate Nidovirus Links Coronavirus and Potyvirus Homologs. J. Virol.
77: 1415-1426
[Abstract]
[Full Text]
-
Green, K. Y., Mory, A., Fogg, M. H., Weisberg, A., Belliot, G., Wagner, M., Mitra, T., Ehrenfeld, E., Cameron, C. E., Sosnovtsev, S. V.
(2002). Isolation of Enzymatically Active Replication Complexes from Feline Calicivirus-Infected Cells. J. Virol.
76: 8582-8595
[Abstract]
[Full Text]
-
Sosnovtsev, S. V., Garfield, M., Green, K. Y.
(2002). Processing Map and Essential Cleavage Sites of the Nonstructural Polyprotein Encoded by ORF1 of the Feline Calicivirus Genome. J. Virol.
76: 7060-7072
[Abstract]
[Full Text]
-
Thumfart, J. O., Meyers, G.
(2002). Feline Calicivirus: Recovery of Wild-Type and Recombinant Viruses after Transfection of cRNA or cDNA Constructs. J. Virol.
76: 6398-6407
[Abstract]
[Full Text]
-
Babic, N., Rodger, G., Arthur, J., Minson, A. C.
(1999). A study of primary neuronal infection by mutants of herpes simplex virus type 1 lacking dispensable and non-dispensable glycoproteins. J. Gen. Virol.
80: 2403-2409
[Abstract]
[Full Text]